Skip to main content

Table 1 Structural formula, GI50, and pGI50 of the data set

From: Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents

S/No. Structural formula GI50 (μM)   pGI50 (μM)
1n C33H43ClN8O4S 0.023   7.6383
2 C28H34ClN7O6S2 0.04   7.398
3 C28H34ClN7O4S 0.043   7.3665
4 C29H36ClN7O4S 0.015   7.8239
5 C30H38ClN7O4S 0.025   7.6021
6 C30H38ClN7O5S 0.041   7.3872
7 C33H42ClN7O4S 0.077   7.1135
8 n C27H31ClN6O5S 1.2   5.9208
9 C28H33ClN6O4S 0.24   6.6198
10 C32H41ClN8O3S 7.1   5.1487
11 C31H40ClN7O4S 0.3   6.5229
12 C34H46N8O4S 0.027   7.5686
13 C30H39N7O4S 0.043   7.3665
14 C29H37N7O4S 0.19   6.7212
15 C26H27ClF3N7O2 0.26   6.5850
16 C25H26Cl2FN7O2 0.1   7.0000
17 C25H26ClF2N7O2 0.13   6.8861
18 C24H28ClN7O2S 0.22   6.6576
19 n C30H37ClN8O3 0.95   6.0223
20 C27H29ClF3N7O2 1.8   5.7447
21 C27H33ClN8O4S 0.031   7.5086
22 C28H35ClN7O3P 0.026   7.5850
23 C29H37ClN7O3P 0.22   6.6576
24 C26H30ClN6O4P 0.78   6.1079
25 C27H33ClN7O5PS 0.89   6.0506
26 C32H41ClN7O3P 0.041   7.3872
27 C27H31ClN8O3 0.05   7.3010
28 n C29H35ClN8O3 0.079   7.1024
29 C28H31ClN8O4 0.25   6.6021
30 C32H40ClN9O3 0.21   6.6778
31 C27H29ClN8O2 0.44   6.3566
32 C28H31ClN8O2 0.43   6.3665
33 C25H24ClN7O3 1.2   5.9208
34 n C31H36ClN9O2 0.2   6.6989
35 C29H38ClN7O4S 0.7   6.1549
  1. nTest set